KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Ingredients (ALTO) Gains from Sales and Divestitures (2012 - 2025)

Alto Ingredients posted quarterly Gains from Sales and Divestitures of $1.3 million for Q4 2025, down 17.41% year-on-year from $1.6 million in Q4 2024, and down 17.41% on a QoQ basis from $1.6 million in Q4 2024.

Alto Ingredients (ALTO) has 13 years of Gains from Sales and Divestitures data on file, last reported at $1.3 million in Q4 2025.

  • For the quarter ending Q4 2025, Gains from Sales and Divestitures fell 17.41% year-over-year to $1.3 million; the trailing twelve-month figure through Dec 2025 stood at $1.3 million (down 17.41% YoY), and the FY2025 full-year result was $1.3 million, down 17.41% from the prior year.
  • Gains from Sales and Divestitures for Q4 2025 stood at $1.3 million, down from $1.6 million in the prior quarter.
  • Across five years, Gains from Sales and Divestitures topped out at $1.6 million in Q4 2024 and bottomed at $547000.0 in Q4 2023.
  • The 5-year median for Gains from Sales and Divestitures is $1.3 million (2025), against an average of $1.2 million.
  • The widest annual swing landed in 2023, when Gains from Sales and Divestitures tumbled 47.95%; it then soared 191.96% in 2024.
  • A 5-year view of Gains from Sales and Divestitures shows it stood at $1.5 million in 2021, then plunged by 31.08% to $1.1 million in 2022, then sank by 47.95% to $547000.0 in 2023, then jumped by 191.96% to $1.6 million in 2024, then slipped by 17.41% to $1.3 million in 2025.
  • The last three Gains from Sales and Divestitures figures came in at $1.3 million (Q4 2025), $1.6 million (Q4 2024), and $547000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Linde 230.79 Bn 226.84 Bn 4.26 Bn
2 Chemical & Mining Co Of Chile 127.66 Bn 124.93 Bn 778.60 Mn
3 Sherwin Williams 72.51 Bn 72.30 Bn 2.78 Bn
4 Ecolab 70.96 Bn 70.34 Bn 1.85 Bn
5 Air Products & Chemicals 62.15 Bn 63.70 Bn 987.40 Mn
6 Ppg Industries 25.04 Bn 23.57 Bn 1.66 Bn
7 LyondellBasell Industries 21.62 Bn 21.73 Bn 701.00 Mn
8 Albemarle 20.26 Bn 19.42 Bn 500.97 Mn
9 DuPont de Nemours 19.45 Bn 19.56 Bn 602.00 Mn
10 Alto Ingredients 427.79 Mn 399.65 Mn 9.22 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.32 Mn
Dec 31, 2025 1.32 Mn
Dec 31, 2024 1.60 Mn
Dec 31, 2024 1.60 Mn
Dec 31, 2023 547,000.00
Dec 31, 2023 547,000.00
Dec 31, 2022 1.05 Mn
Dec 31, 2022 1.05 Mn
Dec 31, 2021 1.53 Mn
Dec 31, 2021 1.53 Mn
Dec 31, 2020 1.29 Mn
Dec 31, 2020 1.29 Mn
Dec 31, 2018 540,000.00
Dec 31, 2018 540,000.00
Dec 31, 2017 480,000.00
Dec 31, 2017 480,000.00
Dec 31, 2016 250,000.00
Dec 31, 2016 250,000.00
Dec 31, 2015 220,000.00
Dec 31, 2015 220,000.00
Dec 31, 2014 227,000.00
Dec 31, 2014 227,000.00
Dec 31, 2013 142,000.00
Dec 31, 2013 142,000.00
Dec 31, 2012 13,000.00
Dec 31, 2012 13,000.00